Once ‐daily versus twice‐daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible: A randomized trial

Clinical Transplantation,Volume 0, Issue ja, -Not available-.
Source: Clinical Transplantation - Category: Transplant Surgery Authors: Source Type: research